Why Weight Loss Should Be the Primary Goal of Treatment in Type 2 Diabetes Care!

Why Weight Loss Should Be the Primary Goal of Treatment in Type 2 Diabetes Care is organized by ReachMD.

Release Date: 09/15/2022
Expiration Date: 09/15/2023

Overview:
Dropping 15% or More of Body Weight Has a Greater Disease-modifying Effect Than Any Other Glucose-lowering Intervention. Join Drs. Donna Ryan and Juan Pablo Frias as They Discuss Implementing an Upstream Intervention to Weight Loss and Newer Drugs (Gip Agonists, Glp-1 Receptor Agonists, Sglt2 Inhibitors) to Help Your Patients Experience Improved Effects Earlier and for a Longer Duration. Tune in to Find Out How the Novel Dual Gip and Glp-1 Receptor Antagonist Tirzepatide Could Fit Into Your Therapeutic Strategies.

Learning Objectives:
 After Participating in This Educational Activity, Participants Should Be Better Able to:
• Identify Weight Loss as a Primary Target of Treatment in People With Type 2 Diabetes and Obesity
• Formulate Strategies to Intensify Individualized Treatment Combinations That Focus on Weight Loss and Glycemic Control